Takeda Shin (TAKEDA) price today
Not listedLive TAKEDA chart
Takeda Shin (TAKEDA) price details
Takeda Shin price history
Download dataDownload data
Takeda Shin technical analysis
Takeda Shin (TAKEDA) sentiment
About Takeda Shin
Takeda Pharmaceutical is a research-based, global biopharmaceutical leader headquartered in Japan, committed to bringing better health and a brighter future to patients. The company focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology. Driven by patient-centric values, Takeda leverages cutting-edge innovation to deliver highly specialized, transformative medicines globally.
Official links
Website
WhitepaperSocial media and community
X(Twitter)FAQ
What is the current price of Takeda Shin (TAKEDA) in USD?
What is the market capitalization of Takeda Shin (TAKEDA)?
What is the circulating supply of Takeda Shin (TAKEDA)?
What factors influence the price of Takeda Shin (TAKEDA)?
Is Takeda Shin (TAKEDA) a good investment?
Where can I buy Takeda Shin (TAKEDA)?
What are the typical fees when buying Takeda Shin (TAKEDA)?
What are some technical indicators used for analyzing Takeda Shin (TAKEDA)?
Takeda Shin news
Bitcoin Lightning’s security update shuts one door. A critical Linux flaw remains
LND’s security update blocks one demonstrated attack route. Affected Bitcoin Lightning hosts still need a patched Linux kernel and reboot.
BlackRock: Bitcoin Whales Are Swapping Self-Custody For IBIT At Record Pace
BlackRock's Robbie Mitchnick says demand to convert bitcoin into IBIT shares in kind is at a record, with security the top reason as kidnappings and hacks rise.
Solana publishes 11 startup ideas spanning AI and housing futures
Stellar Foundation Backs Marketnode to Expand Tokenized Funds Across Asia-Pacific
Crypto: Ethereum Prepares Two Solutions to Protect Its Smart Contracts
China unifies blockchain and AI filings as two old systems close
Is the Historic Tech Crash Driven by Panic Selling or a Real Cycle Turn?
Andrew Sheets, global head of fixed income at Morgan Stanley, points out that the global manufacturing PMI remains strong, the U.S. yield curve is still positively sloped, and bank loan growth is rising in the U.S., Europe, and Asia. From these key leading indicators, the current sharp adjustment in...
Polymarket Expands Chainlink-Powered 15-Minute Markets to Gold and Silver
